RCAMU
BMY icon

Rothschild & Co Asset Management US’s Bristol-Myers Squibb BMY Stock Holding History

Rothschild & Co Asset Management US’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$107M Buy
1,482,940
+29,296
+2% +$2.21M 1.62% 13
2022
Q3 		$103M Sell
1,453,644
-102,993
-7% -$7.47M 1.77% 10
2022
Q2 		$120M Sell
1,556,637
-64,019
-4% -$4.88M 1.84% 7
2022
Q1 		$118M Buy
1,620,656
+32,524
+2% +$2.18M 1.51% 17
2021
Q4 		$99M Sell
1,588,132
-9,031
-0.6% -$530K 1.16% 28
2021
Q3 		$94.5M Sell
1,597,163
-26,240
-2% -$1.73M 1.17% 24
2021
Q2 		$108M Buy
1,623,403
+59,149
+4% +$3.86M 1.29% 21
2021
Q1 		$98.8M Buy
1,564,254
+249,731
+19% +$15.5M 1.22% 19
2020
Q4 		$81.5M Buy
1,314,523
+694,428
+112% +$42.7M 1.05% 22
2020
Q3 		$37.4M Buy
620,095
+609,574
+5,794% +$36.7M 0.67% 37
2020
Q2 		$619K Hold
10,521
– – 0.01% 299
2020
Q1 		$586K Hold
10,521
– – 0.01% 309
2019
Q4 		$675K Hold
10,521
– – 0.01% 327
2019
Q3 		$534K Buy
10,521
+2,015
+24% +$94.7K 0.01% 337
2019
Q2 		$386K Buy
8,506
+1,158
+16% +$53.9K ﹤0.01% 343
2019
Q1 		$351K Hold
7,348
– – ﹤0.01% 356
2018
Q4 		$382K Sell
7,348
-821
-10% -$44.1K ﹤0.01% 367
2018
Q3 		$507K Hold
8,169
– – 0.01% 364
2018
Q2 		$452K Buy
8,169
+1,779
+28% +$96.1K ﹤0.01% 367
2018
Q1 		$404K Buy
6,390
+354
+6% +$22.8K ﹤0.01% 352
2017
Q4 		$370K Hold
6,036
– – ﹤0.01% 343
2017
Q3 		$385K Sell
6,036
-18,551
-75% -$1.08M ﹤0.01% 335
2017
Q2 		$1.37M Buy
24,587
+689
+3% +$37.5K 0.02% 358
2017
Q1 		$1.3M Buy
23,898
+1,866
+8% +$102K 0.01% 354
2016
Q4 		$1.29M Buy
22,032
+4,676
+27% +$256K 0.02% 371
2016
Q3 		$936K Buy
17,356
+5,333
+44% +$343K 0.02% 345
2016
Q2 		$884K Buy
12,023
+498
+4% +$35.2K 0.02% 357
2016
Q1 		$736K Buy
11,525
+6,983
+154% +$440K 0.01% 318
2015
Q4 		$312K Sell
4,542
-4,531
-50% -$299K 0.01% 368
2015
Q3 		$537K Hold
9,073
– – 0.01% 332
2015
Q2 		$604K Sell
9,073
-3,537
-28% -$233K 0.01% 325
2015
Q1 		$813K Hold
12,610
– – 0.02% 325
2014
Q4 		$744K Sell
12,610
-2,909
-19% -$164K 0.01% 339
2014
Q3 		$794K Sell
15,519
-1,182
-7% -$59K 0.02% 337
2014
Q2 		$810K Buy
16,701
+7,329
+78% +$361K 0.02% 342
2014
Q1 		$487K Sell
9,372
-114,316
-92% -$6.08M 0.01% 355
2013
Q4 		$6.38M Sell
123,688
-131,553
-52% -$6.7M 0.14% 249
2013
Q3 		$11.8M Sell
255,241
-437,739
-63% -$19.2M 0.26% 133
2013
Q2 		$31M Buy
+692,980
New +$30.1M 0.72% 27

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Rothschild & Co Asset Management US's BMY Position: Q4 2022 in Review

Rothschild & Co Asset Management US increased its Bristol-Myers Squibb (BMY) stake by 2% in Q4 2022, buying an estimated $2.21M and bringing the position to 1,482,940 shares worth $107M. The position accounts for 1.62% of the portfolio, ranked #13.

Rothschild & Co Asset Management US first reported a position in BMY in Q2 2013 and has held it in 39 quarters since. The position peaked at $120M in Q2 2022. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Rothschild & Co Asset Management US held 1,482,940 shares of Bristol-Myers Squibb worth $107M as of Q4 2022.
  • Rothschild & Co Asset Management US bought 29,296 Bristol-Myers Squibb shares in Q4 2022, an estimated $2.21M.
  • Bristol-Myers Squibb made up 1.62% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #13 holding.
  • Rothschild & Co Asset Management US first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 39 quarters since.
  • Rothschild & Co Asset Management US's Bristol-Myers Squibb position peaked at $120M in Q2 2022.
  • 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.